VeriTeQ's Patented and FDA Cleared Technology Can Help Medical Device Manufacturers Comply With FDA Proposed Rule for Unique Device Identification - Direct Mark Requirement
7/15/2013 10:34:33 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
DELRAY BEACH, Fla.--(BUSINESS WIRE)--Digital Angel Corporation (“Digital Angel” or the “Company”) (OTC Markets: DIGA), a provider of implantable medical device identification and radiation dose measurement technologies following its recent share exchange with VeriTeQ Acquisition Corporation (“VeriTeQ”), announced today that the patented VeriTeQ “Q Inside” radio frequency identification (“RFID”) microchip, cleared by the U.S. Food and Drug Administration (“FDA”), can help implantable medical device manufacturers comply with the FDA’s Proposed Rule for Unique Device Identification (“UDI”) – Direct Mark requirement.
Help employers find you! Check out all the jobs and post your resume.
comments powered by